therapeutics - World Future

Sign in Subscribe

therapeutics

A collection of 2 posts

Rewrite Therapeutics A New Acquisition by Intellia

Rewrite Therapeutics A New Acquisition by Intellia

Biotechnology startup Rewrite Therapeutics Inc. has been acquired by Intellia Therapeutics Inc. in a potential $200 million deal that will be a windfall for Rewrite investors. Venture-capital firm Civilization Ventures in 2020 and 2021 led financings totaling $2.1 million in Berkeley, Calif.-based gene-editing startup Rewrite, said Civilization General

Base for the commercialization of immune cell therapeutics launched in China

Base for the commercialization of immune cell therapeutics launched in China

GUANGZHOU, China, — The inauguration ceremony of Biosyngen Pte. Ltd., joint projects and Biosyngen biological production base was held in China-Singapore Guangzhou Knowledge City (CSGKC), on December 28, 2021. Government officials from Guangzhou Huangpu District and development district, General-Consulate of the Republic of Singapore in Guangzhou, Enterprise Singapore (ESG) attended the